Sign Up to like & get
recommendations!
0
Published in 2017 at "Cell Death and Differentiation"
DOI: 10.1038/cdd.2017.102
Abstract: The blockade of inhibitory receptors such as CTLA-4 (CD152) is being used as immune-checkpoint therapy, offering a powerful strategy to restore effective immune responses against tumors. To determine signal components that are induced under the…
read more here.
Keywords:
mediated posttranslational;
ctla;
ctla mediated;
posttranslational modifications ... See more keywords